Vancomycin Therapy for Induction and Maintenance of Remission in a Patient with Refractory Ulcerative Colitis and Primary Sclerosing Cholangitis: A Case Report and Literature Review
This case report, along with others we reviewed, suggests that vancomycin treatment should be considered as a treatment for ulcerative colitis and primary sclerosing cholangitis patients after conventional therapies for the colitis prove ineffective.
Authors
- Ning Lang (ORCID: https://orcid.org/0000-0003-1860-2918)
- Tomer Hoffman (ORCID: https://orcid.org/0000-0003-3535-6835)
- Abraham R. Eliakim
- Yana Davidov (ORCID: https://orcid.org/0000-0002-6524-1644)
- Bella Ungar
- Sivan Harnik (ORCID: https://orcid.org/0000-0001-6939-2688)
- Shomron Ben‐Horin
Institutions
- Tel Aviv University (IL)
- Sheba Medical Center (IL)
Publication Details
- Journal
- Case Reports in Gastroenterology
- Published
- 2025-05-06
- DOI
- https://doi.org/10.1159/000544161
- Citations
- 1
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 1.82